CD73: an emerging checkpoint for cancer immunotherapy

S Chen, DA Wainwright, JD Wu, Y Wan, DE Matei… - …, 2019 - Taylor & Francis
CD73 is a novel immune checkpoint associated with adenosine metabolism that promotes
tumor progression by suppressing antitumor immune response and promoting …

Purine-metabolising enzymes and apoptosis in cancer

M Camici, M Garcia-Gil, R Pesi, S Allegrini, MG Tozzi - Cancers, 2019 - mdpi.com
The enzymes of both de novo and salvage pathways for purine nucleotide synthesis are
regulated to meet the demand of nucleic acid precursors during proliferation. Among them …

Distinct roles of adenosine deaminase isoenzymes ADA1 and ADA2: a pan-cancer analysis

Z Gao, L Yang, C Liu, X Wang, W Guo… - Frontiers in …, 2022 - frontiersin.org
Objective Adenosine deaminase (ADA) plays an important role in immune response, which
includes two isoenzymes: ADA1 and ADA2. This study aims to explore the roles of ADA1 …

A metabolism-related gene prognostic index bridging metabolic signatures and antitumor immune cycling in head and neck squamous cell carcinoma

K Du, J Zou, B Wang, C Liu, M Khan, T Xie… - Frontiers in …, 2022 - frontiersin.org
Background In the era of immunotherapy, predictive or prognostic biomarkers for head and
neck squamous cell carcinoma (HNSCC) are urgently needed. Metabolic reprogramming in …

Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients

A Bopp, KS De Bona, LP Bellé… - Fundamental & …, 2009 - Wiley Online Library
Syzigium cumini (L.) Skeels from the Myrtaceae family is among the most common medicinal
plants used to treat diabetes in Brazil. Leaves, fruits, and barks of S. cumini have been used …

De novo assembly of a haplotype-resolved human genome

H Cao, H Wu, R Luo, S Huang, Y Sun, X Tong… - Nature …, 2015 - nature.com
The human genome is diploid, and knowledge of the variants on each chromosome is
important for the interpretation of genomic information. Here we report the assembly of a …

Adenosinergic signaling as a target for natural killer cell immunotherapy

J Wang, S Matosevic - Journal of Molecular Medicine, 2018 - Springer
Purinergic signaling through adenosine plays a key role in immune regulation. Hypoxia-
driven accumulation of extracellular adenosine results in the generation of an …

Targeting adenosine with adenosine deaminase 2 to inhibit growth of solid tumors

L Wang, LM Londono, J Cowell, O Saatci, M Aras… - Cancer Research, 2021 - AACR
Extracellular adenosine in tumors can suppress immune responses and promote tumor
growth. Adenosine deaminase 2 (ADA2) converts adenosine into inosine. The role of ADA2 …

Plasma proteomic analysis in non-small cell lung cancer patients treated with PD-1/PD-L1 blockade

M Eltahir, J Isaksson, JSM Mattsson, K Kärre, J Botling… - Cancers, 2021 - mdpi.com
Simple Summary Immunotherapy leads to highly variable responses in lung cancer patients.
We assessed the value of a blood-based test to predict which patients would benefit from …

Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor‐dependent mechanisms

B Kutryb‐Zajac, P Koszalka… - Journal of cellular …, 2018 - Wiley Online Library
The activity of a cell‐surface ecto‐adenosine deaminase (eADA) is markedly increased in
the endothelial activation and vascular inflammation leading to decreased adenosine …